Clinical Trial Update: Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study of PF-05231023 in adults with poor lipid control, with and without Type 2 diabetes mellitus; the trial is completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-05231023

Snippet

Sponsor: Pfizer | Conditions: Diabetes Melliuts, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2015-01-14